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StrokeBrain injury following stroke affects neurogenesis in the adult mammalian brain. However, a complete under-
standing of the origin and fate of the endogenous neural stem cells (eNSCs) in vivo is missing. Tools and technol-
ogy that allow non-invasive imaging and tracking of eNSCs in living animals will help to overcome this hurdle.
In this study, we aimed tomonitor eNSCs in a photothrombotic (PT) strokemodel using in vivo bioluminescence
imaging (BLI). In a first strategy, inducible transgenic mice expressing firefly luciferase (Fluc) in the eNSCs were
generated. In animals that received stroke, an increased BLI signal originating from the infarct region was ob-
served. However, due to histological limitations, the identity and exact origin of cells contributing to the in-
creased BLI signal could not be revealed. To overcome this limitation, we developed an alternative strategy
employing stereotactic injection of conditional lentiviral vectors (Cre-Flex LVs) encoding Fluc and eGFP in the
subventricular zone (SVZ) of Nestin-Cre transgenicmice, thereby specifically labeling the eNSCs. Upon induction
of stroke, increased eNSC proliferation resulted in a significant increase in BLI signal between 2 days and 2 weeks
after stroke, decreasing after 3 months. Additionally, the BLI signal relocalized from the SVZ towards the infarct
region during the 2 weeks following stroke. Histological analysis at 90 days post stroke showed that in the peri-
infarct area, 36% of labeled eNSCprogenydifferentiated into astrocytes,while 21% differentiated intomatureneu-
rons. In conclusion,we developed and validated a novel imaging technique that unequivocally demonstrates that
nestin+ eNSCs originating from the SVZ respond to stroke injury by increased proliferation, migration towards
the infarct region and differentiation into both astrocytes and neurons. In addition, this new approach allows
non-invasive and specific monitoring of eNSCs over time, opening perspectives for preclinical evaluation of can-
didate stroke therapeutics.
© 2014 Elsevier Inc. All rights reserved.bromo-2′-deoxyuridine; CC, corpus callosum; Cre-Flex, Cre-mediatedflip-excision; DCX, doublecortin; eNSCs, endogenous neu-
cidic protein; LV, lentiviral vector; MCAO, middle cerebral artery occlusion; MRI, magnetic resonance imaging; NeuN, neuronal
aphy; PT, photothrombotic; RMS, rostral migratory stream; SGZ, subgranular zone; SVZ, subventricular zone.
lar Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Kapucijnenvoer 33,
: +32 16 33 63 36.
robiology and Gene Therapy, Department of Neurosciences, KU Leuven, Kapucijnenvoer 33, VCTB+5 bus 7001, B-3000 Leuven,
jsbers), veerle.baekelandt@med.kuleuven.be (V. Baekelandt).
bers), http://www.kuleuven.be/molmedsame (V. Baekelandt).
ect.com).
145C. Vandeputte et al. / Neurobiology of Disease 69 (2014) 144–155Introduction
The presence of endogenous neural stem cells (eNSCs) in the adult
mammalian brain, including human brain, is now widely accepted
(Altman, 1962, 1963; Curtis et al., 2005; Eriksson et al., 1998). Two
brain regions, i.e. the SVZ of the lateral ventricles and the subgranular
zone (SGZ) of the hippocampal dentate gyrus, are recognized as primary
regions of adult neurogenesis (Ming and Song, 2005). Under physiolog-
ical conditions, eNSCs in the SVZ divide and their progeny migrates
tangentially via the rostral migratory stream (RMS) to the olfactory
bulb (OB). Upon arrival in the OB, neuroblasts differentiate into local
interneurons and integrate into the glomerular and granular layers
(Alvarez-Buylla and Garcia-Verdugo, 2002). Pathological conditions,
including brain injury and stroke, affect adult neurogenesis (Curtis
et al., 2005; Gray and Sundstrom, 1998; Liu et al., 1998). Stroke, a com-
mon cause of morbidity and mortality worldwide, deprives the brain of
oxygen and glucose (Flynn et al., 2008). Following stroke, neurogenesis
augments the number of immature neurons in the SVZ (Jin et al., 2001;
Zhang et al., 2008). Neuroblasts (positive for the marker doublecortin,
DCX)migrate towards sites of ischemic damage andupon arrival, pheno-
typicmarkers ofmature neurons can be detected (Arvidsson et al., 2002;
Parent et al., 2002). On the other hand, retroviral labeling of the SVZ
showed that cells migrated to the lesion and differentiated into glia
(Goings et al., 2004), demonstrating that following injury, the SVZ can
generate both neural cell types. Some studies showed that SVZ-derived
progenitors can differentiate into medium spiny neurons in the striatum
after stroke (Collin et al., 2005; Parent et al., 2002), whereas others
claimed that the newborn cells are fate restricted to interneurons or
glia (Deierborg et al., 2009; Liu et al., 2009).Whether SVZ neural progen-
itors can alter their fate, integrate in the injured circuits and survive for
long time periods is still a matter of debate (Kernie and Parent, 2010).
Up till now, specific labeling of eNSCs in the SVZ and the follow-up of
the migration of their progeny to the ischemic area over time has not
yet been shown.
Apart from the primary neurogenic niches, other brain regions, e.g.
the cortex, contain cells that become multipotent and self-renew after
injury (Komitova et al., 2006). Althoughmature astrocytes do not divide
in healthy conditions, they can dedifferentiate and proliferate after stab
wound injury and stroke (Buffo et al., 2008; Sirko et al., 2013). While
these proliferating astrocytes remained within their lineage in vivo,
they formed multipotent neurospheres in vitro (Buffo et al., 2008;
Shimada et al., 2010). Therefore, these reactive astrocytes may represent
an alternative source ofmultipotent cells thatmaybe beneficial in stroke.
A major hurdle when studying endogenous neurogenesis is the lack
of methods to monitor these processes in vivo, in individual animals
over time. We and others attempted to label eNSCs by injection of
iron oxide-based particles in the lateral ventricle or SVZ (Nieman
et al., 2010; Shapiro et al., 2006; Sumner et al., 2009; Vreys et al.,
2010), or by lentiviral vectors (LVs) encoding a reporter gene into the
SVZ (Vande Velde et al., 2012) to monitor stem cell migration along
the RMS with magnetic resonance imaging (MRI). Although MRI pro-
vides high resolution, it suffers from low in vivo sensitivity and gives
no information on cell viability and non-specific signal detection cannot
be excluded. Rueger et al. described in vivo imaging of eNSCs after focal
cerebral ischemia via positron emission tomography (PET) imaging
(Rueger et al., 2010), however, the cells responsible for the PET signal
could not be identified. Alternatively, transgenic mice expressing Fluc
driven by a DCX promoter allowed monitoring of adult neurogenesis
using in vivo BLI (Couillard-Despres et al., 2008). However, the robust
BLI signal emitted from the SVZ, leading to scattering and projection
of these photons to the OB, impedes direct visualization of eNSC migra-
tion from the SVZ towards the OB. Moreover, when the DCX+
neuroblasts differentiate intomature neurons, they lose the Fluc expres-
sion. In a first part of the present study, we generated inducible trans-
genic mice that express Fluc in the nestin+ eNSCs, to monitor a
stroke-induced eNSC response with BLI.An alternative strategy to efficiently and stably introduce Fluc in the
eNSCs is by stereotactic injection of LVs into the SVZ, which allowed us
and others to monitor the migration of eNSCs and their progeny
towards the OB with BLI (Guglielmetti et al., 2013; Reumers et al.,
2008). However, since LVs transduce both dividing and post-mitotic
cells, not only eNSCs but also neighboring astrocytes and mature
neurons are labeled after injection of constitutive LVs in the SVZ
(Geraerts et al., 2006). As a result, in line with the data described in
transgenic mice, a high BLI signal emerges from the site of injection
that interferes with the measurement of the migrating cells (Reumers
et al., 2008). To overcome the latter, we developed new conditional
Cre-Flex LVs in a second part of this study. These Cre-Flex LVs incorpo-
rate Cre-lox technology, allowing that Fluc and eGFP are restrictively
expressed in eNSCs after injection in the SVZ of transgenic Nestin-Cre
mice. While numerous research groups have previously described
stroke-induced eNSC behavior (Arvidsson et al., 2002; Parent et al.,
2002), we here report for the first time successful in vivo imaging and
characterization of long-term eNSC responses after stroke.
Materials & methods
Animals
Animal studies were performed in accordance with the current eth-
ical regulations of the KU Leuven. Nestin-CreERT2 mice (a kind gift from
Dr. Amelia J. Eisch (University of Texas Southwestern Medical Center,
Dallas, TX) (Lagace et al., 2007)) and B6.Cg-Tg(Nes-cre)1Kln/J
(Jax labs stock nr 003771, (Tronche et al., 1999)) were crossbred
with C57BL/6-Tyrc-2J/J (Jax labs, stock nr 000058), creating white
furred albinomice in a C57BL/6 genetic background.White furred in-
ducible Nestin-CreERT2 mice were crossbred with ROSA26-LoxP-
stop-LoxP(L-S-L)-luciferase transgenic mice (Safran et al., 2003) (Jax
labs, stock nr 005125), indicated as Nestin-CreERT2/Flucmice. To induce
Fluc expression,mice received tamoxifen intraperitoneally (ip) or orally
at 180 mg/kg dissolved in 10% EtOH/90% sunflower oil for 5 consecutive
days. BrdU was administered as previously published (Geraerts et al,
2006). For the stroke follow-up, Fluc expression was induced in 11
Nestin-CreERT2/Fluc mice by oral tamoxifen treatment. Four days
later, the animals were divided into 2 groups: 8 mice received a PT
stroke and 2 mice received a sham treatment; one mouse died during
tamoxifen induction. Three Cre-negative littermates that received a
stroke were added as controls.
White furred B6.Cg-Tg(Nes-cre)1Kln/J mice, here referred to as
Nestin-Cre mice, were stereotactically injected with Cre-Flex LV in the
SVZ at the age of 8 weeks. One week after stereotactic injection,
Nestin-Cre mice received a PT stroke (n = 33) or sham treatment
(n = 10). A Cre-negative littermate that received a stroke was added
as control.
Micewere genotyped by PCRusing genomicDNA and primers previ-
ously described (Lagace et al., 2007).
Lentiviral vector construction and production
We designed a new conditional LV system based on the Cre/loxP
mechanism, here referred to as Cre-Flex (Cre-mediated flip-excision).
The Cre-Flex LVs carry a reporter cassette encoding eGFP and Fluc
flanked by a pair of mutually exclusive lox sites. The reporter cassette
is activated after Cre recombination (flip-excision, Fig. 3A). For the con-
struction of the Cre-Flex plasmids, we used the pCHMWS-eGFP plasmid
as a backbone (Geraerts et al., 2006). As illustrated in Fig. 3A, pairs of
heterotypic loxP_loxm2 recombinase target sites were cloned respec-
tively, upstream and downstream of eGFP using synthetic oligonucleo-
tide adaptors. To enable efficient recombination, 46-bp spacers were
inserted in between both lox sites. In this plasmid, eGFP was replaced
by the coding sequence for eGFP-T2A-Fluc (Ibrahimi et al., 2009). All
cloning steps were verified by DNA sequencing. Cre-Flex LVs were
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described previously (Geraerts et al., 2005; Ibrahimi et al., 2009). Before
the start of the in vivo experiments, the LV-Cre-Flexwas validated in cell
culture (Supplementary Fig. 1).Lentiviral vector injections
Mice were anesthetized by ip injection of ketamine (75 mg/kg;
Ketalar, Pfizer, Brussels, Belgium) and medetomidin (1 mg/kg; Domitor,
Pfizer), and positioned in a stereotactic head frame (Stoelting, Wood
Dale, Illinois, USA). Using a 30-gaugeHamilton syringe (VWR Internation-
al, Haasrode, Belgium), 4 μL of highly concentrated Cre-Flex LV was
injected in the SVZ at a rate of 0.25 μL/min. After injection of 2 μL, the nee-
dle was raised slowly over a distance of 1 mm. After injection of the total
volume the needlewas left in place for an additional 5min to allow diffu-
sionbefore being slowly redrawn from the brain. SVZ injectionswere per-
formed at the following coordinates relative to Bregma: anteroposterior
0.5 mm, lateral−1.5 mm and dorsoventral−3.0–2.0 mm. After surgery,
anesthesia was reversed with an ip injection of atipamezol (0.5 mg/kg;
Antisedan, Orion Pharma, Newbury, Berkshire, UK).Stroke models
Anesthesia was provided with 2% isoflurane/O2 gas anesthesia
(Halocarbon Products Corporation, New Jersey, USA) through a face-
mask. The PT strokes were induced according to Vandeputte et al.
(2011). Briefly, a vertical incision was made between the right orbit
and the external auditory canal. Next, the scalp and temporalis muscle
were retracted. After intravenous (iv) injection of the photosensitizer
rose Bengal (20 mg/kg; Sigma Aldrich, St Louis, USA) through the tail
vein, photoillumination was performed for 5 min. Photoillumination
with green light (wave length, 540 nm; band width, 80 nm) was
achieved using a xenon lamp (model L-4887; Hamamatsu Photonics,
Hamamatsu City, Japan) with heat-absorbing and green filters. The irra-
diation at intensity 0.68 W/cm2 was directed with a 3-mm optic fiber,
the head of whichwas placed on the sensorymotor cortex. Focal activa-
tion of the photosensitive dye resulted in local endothelial cell injury
leading to microvascular thrombosis and circumscribed cortical infarc-
tions (Watson et al., 1985). Sham-operated animals underwent the
exact same procedure as the animals with a stroke, except for the
5 min photoillumination.
Transient occlusion of the middle cerebral artery (MCA) was done
using the intraluminal filament technique previously described
(Dirnagl and members of the MCAO-SOP group, 2009), although in
our experiments the MCA was occluded for 20 min.MR imaging
For MRI data acquisition, mice were anesthetized with isoflurane
(Halocarbon) in O2 (2.5% for induction, 1.5–2% for maintenance). MR
images were acquired using a Bruker Biospec 9.4 Tesla small animal
MR scanner (Bruker BioSpin, Ettlingen, Germany; horizontal bore,
20 cm) using a cross-coil setup consisting of a 7.2 cm linearly polarized
resonator for transmission and amouse head surface coil for signal recep-
tion as described before (Oosterlinck et al., 2011; Vandeputte et al., 2011).
In brief, the following protocols were used: (a) T2maps using aMSME se-
quence (10 echoes with 10 ms spacing, first TE = 10 ms, TR = 2000 ms,
16 nterlaced slices of 0.4 mm, 100 μm2 in plane resolution); (b) T2-
weighted MRI using a RARE sequence (TEeff = 71 ms, TR = 1300 ms,
100 μm3 isotropic resolution) and (c) high-resolution T2*-weighted 3D
FLASH (TR = 100 ms, TE = 12 ms, 100 μm3 isotropic resolution). The
location of the needle tract after stroke was measured with the Bruker
Biospin software Paravision 5.x.In vivo bioluminescence imaging
The mice were imaged in an IVIS 100 system (PerkinElmer,
Waltham, MA, USA). Anesthesia was induced in an induction chamber
with 2% isoflurane in 100% oxygen at a flow rate of 1 L/min and main-
tained in the IVIS with a 1.5%mixture at 0.5 L/min. Before each imaging
session, themicewere injected ivwith 126 mg/kg D-luciferin (Promega,
Leiden, the Netherlands) dissolved in PBS (15 mg/mL). Next, they were
positioned in the IVIS and consecutive 1 or 2min (depending on the ex-
periment) frames were acquired until the maximum signal was
reached. Data are reported as the total flux (p/s/cm2/sr) from a specific
region of interest (ROI) of 12.5 mm2.
Ex vivo bioluminescence imaging
Immediately after in vivo BLI imaging, mice were sacrificed by
cervical dislocation, decapitated and the brain was dissected. The
brain was placed in an acrylic brain matrix (Harvard apparatus,
Holliston, MA, USA) and sliced in 1.0 mm-thick sections. Next, these
sections were imaged for 1 min in the IVIS.
Immunohistochemistry
Animals were sacrificed with an ip overdose (15 μL/g) of pentobar-
bital (Nembutal, CEVA Santé Animale, Libourne, France) and trans-
cardially perfused with 4% paraformaldehyde (PFA) in PBS. Brains
were removed and postfixed for 24 h with PFA. 50 μm thick coronal
sections were treated with 3% hydrogen peroxide and incubated over-
night with the primary antibody, rabbit anti-eGFP (made in-house,
1:10000 (Baekelandt et al., 2003)) or a rabbit anti-Cre recombinase
(1:3000 (Lemberger et al., 2007)), in 10% normal swine serum and
0.1% Triton X-100. The sections were then incubated in biotinylated
swine anti-rabbit secondary antibody (diluted 1:300; Dako, Glostrup,
Denmark), followed by incubation with streptavidin horseradish
peroxidase complex (Dako). Immune-reactive cells were detected by
3,3′-diaminobenzidine, using H2O2 as a substrate. For 5-bromo-2′-
deoxyuridine (BrdU) detection, sections were pre-treated for 30 min in
2 N HCl at 37 °C, blocked in 0.1 M borate buffer for 20 min, rinsed
3 × 10 min in PBS before incubation with rat anti-BrdU (1:400, Accurate
chemical, NY, USA) in 10% horse serum, followed by incubation with bio-
tinylated donkey anti-rat secondary antibody (Jackson ImmunoResearch
Laboratories). The number of eGFP+cellswas estimatedwith anunbiased
stereological counting method, by employing the optical fractionator
principle in a computerized system, as described previously (Baekelandt
et al., 2002) (StereoInvestigator, MicroBright-Field, Magdeburg,
Germany).
For immunofluorescent stainings, sections were treated with PBS-
10% horse serum-0.1% Triton X-100 for 1 h. Next, sectionswere incubat-
ed overnight at 4 °C in PBS–0.1% Triton X-100 with the following
antibodies: chicken anti-eGFP (1:500, Aves labs, Tigard, OR) and rabbit
anti-glial fibrillary acidic protein (GFAP) for astroglial cells and type B
cells (1:500, Dako), goat anti-doublecortin (DCX) for migrating
neuroblasts (1:200, Santa Cruz Biotechnology), or rabbit anti-neuronal
nuclei (NeuN) for mature neurons (1:1000, EnCor Biotechnology Inc.,
Gainesville, FL, USA). The next day, sections were incubated with the
appropriate mixture of the following fluorescently labeled secondary
antibodies at room temperature for 2 h: donkey anti-chicken (FITC,
1:200, Jackson ImmunoResearch Laboratories), donkey anti-goat
(Alexa 555, 1:400, Molecular Probes) or donkey anti-rabbit (Alexa
647, 1:400, Molecular Probes). Next, the sections were washed in PBS-
0.1% Triton X-100 andmounted withMowiol. Fluorescence was detect-
ed with a confocal microscope (FV1000, Olympus) with a 488 nm, a
559 nmand a 633 nm laser. The signal from each fluorochromewas col-
lected sequentially. For the quantification of double and triple positive
cells, all GFP+ cells in the right SVZ, corpus callosum and stroke region
(one section per animal) were analyzed at 40× using z-plane confocal
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tions of 18 μm z-stacks, except Fig. 6F which is a single focal plane.
Brightness, contrast and background were adjusted equally for the en-
tire image using ‘brightness and contrast’ controls in Image J.
Statistics
All statistical analyses were performed in Prism 5.0 (GraphPad Soft-
ware). The statistical tests that were used are indicated in the figure
legends. Data are represented as mean ± standard error of the mean
(s.e.m.). p-values are indicated as follows: *p b 0.05, **p b 0.01, and
***p b 0.001.
Results
Nestin-CreERT2/Fluc mice show an increased BLI signal after stroke
To monitor a stroke-induced eNSC response with BLI we initially
used a transgenic strategy, where Nestin-CreERT2 mice were crossbredFig. 1. Long-term follow-up of Nestin-CreERT2/Fluc mice with BLI. (A,B) A long-term follow-up
CreERT2/Fluc mice (n = 5) and Cre-negative littermates (n = 4). BLI was performed 1 week
originating from the SVZ (A) and OB (B) was not significantly different from the background s
the OB was detected over time (B). (C) BLI images of a representative Nestin-CreERT2/Fluc mo
20 weeks after induction shows a higher signal in the neurogenic regions in Nestin-CreERT2/F
20 weeks shows a 2 to 3 fold higher signal emitted from the SVZ and the OB in the Nestin-Crewith ROSA26-loxP-stop-loxP(L-S-L)-luciferase transgenic mice. In the
resulting Nestin-CreERT2/Fluc mice, Fluc expression is induced specifi-
cally in the nestin+ eNSCs following administration of tamoxifen
(Lagace et al., 2007). First, wemonitored themigration of eNSC progeny
from the SVZ to the OB with BLI in healthy adult Nestin-CreERT2/Fluc
mice. BLI was performed 1 week before and 1, 4, 8, 15 and 20 weeks
after tamoxifen administration in healthy Nestin-CreERT2/Fluc mice
(n = 5) or Cre-negative littermates (n = 4). At all time points investi-
gated, no distinct in vivo BLI signals could be detected in the neurogenic
regions of Nestin-CreERT2/Fluc mice and in Cre-negative littermates
(Figs. 1A–C). Furthermore, therewas no significant increase in BLI signal
originating from theOB over time inNestin-CreERT2/Flucmice (Figs. 1 B,
C). Although nodifferences in in vivoBLI signal could bedetected, ex vivo
BLI analysis showed a 2 to 3 fold higher BLI signal in the OB and SVZ of
Nestin-CreERT2/Fluc mice compared to Cre-negative littermates (Figs. 1
D,E). This indicates that Fluc is indeed expressed in eNSCs of the SVZ and
in the progeny arriving in the OB, as is evidenced by ex vivo BLI, but the
number of labeled cells is too low for in vivo detection. The latter might
be explained by a low neurogenic potential in the Nestin-CreERT2/Flucof the BLI signal originating from the neurogenic brain regions was performed in Nestin-
before and 1, 4, 8, 15 and 20 weeks after ip administration of tamoxifen. The BLI signal
ignal in Cre-negative littermates. Furthermore, no increase in BLI signal originating from
use 1 week before and 4, 8 and 15 weeks after tamoxifen administration. (D) Ex vivo BLI
luc mice compared to Cre-negative littermates. (E) Quantification of ex vivo BLI signals at
ERT2/Fluc mice compared to Cre-negative littermates.
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have been described (Kempermann et al., 1997). Therefore, we evaluat-
ed the neurogenic potential in Nestin-CreERT2/Fluc mice and in age-
matched C57BL/6 mice using BrdU (Supplementary Fig. 2) and showed
that proliferation in the SVZ and number of newborn neurons arriving
in the OB was not different. In conclusion, neurogenesis in SVZ and mi-
gration to the OB could not be monitored with in vivo BLI in healthy
adult Nestin-CreERT2/Fluc mice.
Next, we investigated whether stroke-induced neurogenesis could
be monitored in Nestin-CreERT2/Fluc mice. Nine days after tamoxifen
administration, mice either received a PT stroke in the right sensorimo-
tor cortex (n = 8) or a sham treatment (n = 2) (Fig. 2A). Cre-negative
littermates with stroke were included as controls (n = 3). BLI was
performed one day prior to and 7, 15, 22 and 33 days after surgery. In
Nestin-CreERT2/Fluc mice receiving sham treatment and in Cre-
negative littermates receiving stroke, no in vivo BLI signal could be
detected (Figs. 2B,C). However, in 6 out of 8 Nestin-CreERT2/Fluc mice
that received a stroke, a distinct BLI signal emerging from the stroke
area was detected starting at day 7 (Figs. 2B,C), compared to the base-
line scan before surgery, being 3.2 ± 0.4 fold higher at 7 days
(p b 0.001), 4.2 ± 0.5 fold higher at 15 days (p b 0.001), 2.1 ± 0.4
fold higher at 22 days (p b 0.05) and 1.9 ± 0.3 fold higher at 33 days
(not significant) after surgery (Fig. 2B). Ex vivo analysis was performed
after 33 days and demonstrated in 3 out of 6 animals a BLI signal emerg-
ing from the stroke region, corroborating the in vivomeasurements and
excluding that the signal originated from the skin (Fig. 2D). Although
the BLI signal emerging from the stroke area could result from accumu-
lation of migrating SVZ progeny, alternatively, mature astrocytes in the
infarction zone might have dedifferentiated upon injury, resulting in
nestin and subsequent Fluc activity (Buffo et al., 2008). Thus, although
a stroke-induced neurogenic response can be detected with in vivo BLI
in Nestin-CreERT2/Fluc mice, the exact origin of the BLI signal could
not be identified.Fig. 2. Stroke induces an increase in BLI signal in Nestin-CreERT2/Flucmice localized to the peri-
after a PT stroke. 9 days after the start of tamoxifen induction, mice received PT stroke (n = 8)
(n = 3). (B) Compared to the baseline scan performed before surgery, the in vivo BLI signal orig
way ANOVA p b 0.001, followed by Dunnett's post test p b 0.001), 4.2 ± 0.5 fold higher at 15
p b 0.05) and 1.9± 0.3 fold higher at 33 days (not significant) in stroke animals. (C) Representa
stroke, a distinctive in vivo BLI signal originating from the stroke region could be detected, whic
signals 33 days after stroke. In 3 of the 6 animals with an increased in vivo stroke BLI signal, anDevelopment and validation of conditional Cre-Flex LVs for specific eNSC
labeling
To overcome this limitation, we engineered a viral vector-based
system, containing a Cre-Flex cassette. The LV encodes a reporter cas-
sette, here encoding eGFP and Fluc linked by a peptide 2A sequence,
in reverse orientation relative to the promoter, that is only activated
in cells expressing Cre recombinase (LV-Cre-Flex Nb eGFP-T2A-Fluc;
Fig. 3A). We injected LV-Cre-Flex Nb eGFP-T2A-Fluc into Nestin-Cre
transgenic mice, which express Cre recombinase under the control of
the rat nestin promoter and enhancer, limiting Cre expression to
eNSCs. As a result, eGFP and Fluc expression is specifically activated in
eNSCs and their progeny. The use of 2A-like peptides results in equimo-
lar expression of Fluc and eGFP reporter genes (Ibrahimi et al., 2009),
enabling BLI and immunohistochemistry for eGFP to identify trans-
duced cells in the same animal.
The LVs were injected in the SVZ of healthy adult Nestin-Cre mice
(n = 9) to label the eNSCs and the migration of the progeny to the OB
was monitored by BLI at 1, 8, 15, 20 and 27 weeks after injection (Figs.
3B,C). In linewith earlier data (Reumers et al., 2008), a distinct BLI signal
emerged from the OB at 8 weeks, which gradually increased over time
being 3.2 ± 0.3 fold higher at 8 weeks (not significant), 4.3 ± 0.8 fold
higher at 15 weeks (p b 0.01), 5.1 ± 1.1 fold higher at 20 weeks
(p b 0.001) and 5.5±1.4 fold higher at 27 weeks (p b 0.001) compared
to 1 week after injection (Figs. 3B,C). No BLI signal from the OB could be
identified in WT mice 1 or 15 weeks after injection of the Cre-Flex LV
(n = 4) (Figs. 3B, C). Immunohistochemical detection of Cre+ and
eGFP+ cells showed specific labeling of cells lining the ventricle wall
and labeled eNSC progeny in theOB (Figs. 3D–E–F, respectively). In con-
clusion, the conditional LV-based labeling system combines specific and
efficient labeling of the eNSC population of the SVZ with the possibility
for immunohistochemical analysis of the transduced eNSCs and their
progeny. Additionally, migration of the eNSC progeny to the OB couldinfarct area. (A) Experimental time line for BLI measurements of Nestin-CreERT2/Flucmice
or sham (n= 2) surgery. Cre-negative littermates with stroke were included as controls
inating from the stroke regionwas 3.2± 0.4 fold higher at 7 days (repeatedmeasures one-
days (Dunnett's post test p b 0.001), 2.1 ± 0.4 fold higher at 22 days (Dunnett's post test
tive in vivo BLI signals 33 days after stroke. In 6 out of 8 Nestin-CreERT2/Flucmice receiving
h could not be detected in sham or in Cre-negative animals. (D) Representative ex vivo BLI
ex vivo BLI spot in the stroke region could be detected.
Fig. 3. Validation of conditional LV-Cre-Flex for specific eNSC labeling. (A) Schematic representation of the conditional Cre-Flex LV. The cDNA cassette is flanked by one pair of loxP sites
(closed arrowheads) and one pair of loxm2 sites (open arrowheads). In the presence of Cre recombinase, the DNA sequence between opposing sites is inversed (Flip), resulting in the
positioning of two homotypic sites in the same orientation. The DNA sequence that is flanked by similarly oriented sites is excised (Excision). Cre-mediated inversion can start at the
loxP or the loxm2 sites, but will always result in the same final product after Cre-mediated excision. The end product is an inverted DNA sequence, flanked by two heterotypic sites
that cannot recombine with one another thereby preventing further inversions. (B) Cre-Flex Nb eGFP-T2A-Fluc LV were injected in the SVZ of black furred Nestin-Cre mice (n = 9) or
Cre-negative littermates (n = 4). The mice were scanned at 1, 8, 15, 20 and 27 weeks post injection. A significant increase in BLI signal originating from the OB was detected over time
in the Nestin-Cre mice (repeated measures one-way ANOVA p = 0.001, followed by Dunnett's post test). (C) Representative BLI images of Nestin-Cre and WT littermates at indicated
time points. Detection of Cre+ (D) and eGFP+ (E,F) cells in the SVZ and OB 4 weeks after injection of Cre-Flex_Fluc Nb eGFP LV in the SVZ of Nestin-Cre mice (D–F) Scale bar = 250 μm.
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CreERT2/Fluc mice.Stroke-induced neurogenic response in the SVZ is detected by BLI and
histology
Cre-Flex LVswere applied tomonitor the eNSC response after stroke
(Fig. 4A). Adult Nestin-Cre mice were stereotactically injected with LV-
Cre-Flex Nb eGFP-T2A-Fluc into the right side of the SVZ. Seven days
post injection, the animals received either a PT stroke in the right senso-
rimotor cortex (n = 21) or sham surgery (n = 9). Stroke lesions were
monitored with MRI 2, 7 and 14 days after surgery (Fig. 4C). BLI
measurements were performed 1 day before (baseline) and 2, 7, 14,
30 and 90 days after surgery (Figs. 4A,B,D). As a control, a Cre-
negative mouse was injected with the LV-Cre-Flex vector and received
a PT stroke. It was monitored until 3 months after stroke, but no BLI
signal could be detected (data not shown). At all time points investigat-
ed, the sham animals showed no difference in BLI signal compared to
the baseline scan (Fig. 4D). However, mice with a PT stroke showed a
4.3 ± 0.8 fold increase in BLI signal at 2 days (p b 0.001), a 6.2 ± 1.6
fold increase at 7 days (p b 0.01), a 7.5 ± 3.3 fold increase at 14 days
(p b 0.05) and a 6.4 ± 3.5 fold increase at 30 days (not significant)
(Fig. 4D). At later time points, the stroke BLI signal decreased until
90 days after stroke.The stroke-induced increase in BLI signal was corroborated by ste-
reological quantification of the number of eGFP+ cells in the SVZ, stria-
tum, corpus callosum (CC) and peri-infarct area (Figs. 5A,B). Most eGFP+
cells were detected in the CC, reaching to the stroke area. In sham ani-
mals, 2116 ± 209 eGFP+ cells (n = 7) were counted and this number
did not change over time. In animals receiving stroke surgery, the num-
ber of eGFP+ cells was significantly higher at 2 days (4123 ± 674,
p b 0.05, n = 7), 7 days (5407 ± 290, p b 0.05, n = 2) and 14 days
(4610 ± 222, p b 0.05, n = 4) after stroke, compared to sham animals
(Fig. 5B). 90 days after stroke, the number of eGFP+ cells decreased
and was significantly lower (2382 ± 375, p b 0.05, n = 7) compared
to 7 and 14 days after stroke, corroborating the results obtained by BLI.
To ensure that the eGFP+ cells originate from labeled eNSCs and not
from reactive astrocytes that upregulate their nestin promoter and thus
Cre upon injury, Cre expression was analyzed 2 days after stroke
(Supplementary Figs. 3A,B). Therewas no Cre upregulation in the ipsilat-
eral SVZ and CC compared to the contralateral hemisphere (Supplemen-
tary Fig. 3A), whereas Cre-positive cells with astrocyte-like morphology
were detected in close proximity of the stroke lesion (Supplementary
Fig. 3B). These cells were mainly present in the cortex on the dorsal
side of the lesion and to a lesser extent on the lateral side of the lesion.
Since the Cre-Flex LVs were injected in the SVZ, which is physically dis-
tant from the stroke region, and since the Cre-Flex LVs specifically label
cells in the SVZ (Fig. 3E), it is unlikely that these distant reactive astro-
cytes were labeled directly via viral vector injection. Taken together,
Fig. 4.BLI detects the increase andmigration of eNSC progeny after PT stroke inNestin-Cremice injectedwith the LV-Cre-Flex. (A) Experimental time line for imaging of the eNSC response
in a PT strokemodel inmice. Seven days after stereotactic injection of LV-Cre-Flex in the SVZ of Nestin-Cremice, the animals received a PT stroke in the right sensorimotor cortex (n=21)
or sham surgery (n = 9). The animals were imaged with BLI and MRI, for additional anatomical information, at indicated time points. (B) Consecutive BLI images of a Nestin-Cre mouse
before and after stroke injury reveal a time-dependent increase of BLI signal and a shift of the BLI signal towards the stroke lesion. Three months after stroke, a second BLI signal can be
discriminated between the eyes, representing migration of labeled eNSC progeny to the OB. This signal could not be distinguished before and 2, 7, 14 days after stroke. (C) Representative
T2-weighted MR image 7 days after stroke surgery of a Nestin-Cre mouse. The stroke region in the right sensory motor cortex is depicted with a red dotted line. (D) Quantification of
relative BLI signal. 2 days after stroke surgery, a 4.3 ± 0.8 fold increase in BLI signal emanating from the SVZ was detected (n = 22) in comparison to the sham animals (n = 9)
(Mann–Whitney test p b 0.001). A more pronounced increase (6.2 ± 1.6 fold) was detected at 7 days (n = 14 versus n = 9) (p b 0.01), 14 days (7.5 ± 3.3 fold increase in stroke
(n =8) versus sham (n=4) animals (p b 0.05)) and at 30 days (6.4±3.5 fold increase in stroke (n=6) versus sham(n=2) animals) after surgery. 90 days after stroke surgery, a relative
photon flux of 2.01 ± 1.1 difference was detected in stroke animals (n= 7) compared to 1.1 ± 1.0 in sham animals (n = 2). (E) Migration of the BLI hot spot towards the stroke region.
Before stroke surgery, the average distance of the BLI spot is 2.56 ± 0.22 mm from the midline (n = 9). 7–14 days after stroke surgery, the average distance of the BLI spot is 4.62 ±
0.25 mm from the midline (n = 9, t-test p b 0.001).
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transient increase in the number of eGFP+ cells, which originated from
labeled eNSCs in the SVZ.
In vivo BLI reveals eNSCmigration to the area of infarction andOB following
PT stroke
Long-term BLI follow-up of stroke animals not only revealed a tran-
sient increase in BLI signal, but also a clear shift of the BLI signal towards
the stroke lesion was apparent (Fig. 4B). To estimate the migration of
the BLI signal after stroke, the distance between the BLI hot spot and
the midline was determined (Fig. 4E). Before stroke surgery, a unifocal
signal originating from the site of injection was detected, which corre-
sponds to labeled cells in the SVZ (average distance of 2.56 ±
0.22 mm from midline). Two days after stroke, a small shift of the BLI
signal towards the contralateral hemisphere was evident (Fig. 4B),
probably due to the induction of edema as was detected by MRI (Sup-
plementary Fig. 4A). At 1 and 2 weeks after stroke, a significant shift
of the BLI spot towards the stroke regionwas observed in 9 out of 10 an-
imals (average distance of 4.62 ± 0.25 mm from midline, p b 0.001
compared to baseline) (Figs. 4B,E), suggesting migration of the eNSCprogeny towards the stroke area. In the sham-operated animals no
shift was detected at any of the time points (data not shown). Since dy-
namic changes of edemaor changes in ventricle size due to loss of viable
brain tissue might affect the location of the BLI signal, the animals were
also imaged with MRI on the same day of the BLI (Fig. 4A). The needle
tract was used as a reference and its shift due to edema formation or
changes in ventricle size was monitored (Supplementary Figs. 4A,B).
The needle tract shift 14 days after stroke compared to the time of injec-
tionwas 0.39± 0.04mm(n=9), whichwas considerably smaller than
the shift of the BLI signal (2.06 mm). Although a small enlargement of
the ventricles was detected in the animals with a PT stroke, its effect
on the migration of BLI signal was limited.
Since most studies have investigated stroke-induced neurogenesis
in models of middle cerebral artery occlusion (MCAO) (Parent et al.,
2002; Thored et al., 2007), a small experiment where animals received
either MCAO (n= 4) or sham surgery (n= 3) was performed (Supple-
mentary Fig. 5). The MCAO model provides MCA territory infarctions,
involving the striatum and the frontoparietal cortex, after the insertion
of a monofilament that blocks the origin of MCA, whereas the PT stroke
model involves the intravenous administration of a photosensitive dye
followed by laser irradiation of any exposed region of the skull.
Fig. 5. Histological characterization of long-term stroke-induced eNSC response. (A) Representative immunohistochemistry for eGFP of the SVZ, CC and stroke area at baseline and 2, 7,
14 days and 3 months after stroke surgery. Most eGFP+ cells were detected in the CC, with some cells reaching the stroke area. The presence of eGFP+ cells surrounding the stroke
area is most pronounced at 14 days and 3 months after surgery. Magnifications of specific details are integrated in the figure. (B) Stereological quantification of the total number of
eGFP+ cells in the SVZ, CC, striatum and stroke area after PT stroke. In sham animals, the number of eGFP+ cells was constant over time and on average 2116 ± 210 eGFP+ cells were
detected (n = 7). In stroke animals, the number of eGFP+ cells was significantly higher at 2 days (4123 ± 674, n = 7), 7 days (5407 ± 290, n = 2) and 14 days (4610 ± 222, n = 4)
after stroke, compared to sham animals (One-way ANOVA p b 0.001, followed by Bonferroni post test p b 0.05, indicated by $). 90 days after stroke, the number of eGFP+ cells was sig-
nificantly lower (2382±375, n= 7, Bonferroni post test p b 0.05, indicated by #) compared to 7 and 14 days after stroke. (C) Representative immunohistochemical images of eGFP+ cells
in the OB of mice with PT stroke at 7, 14 and 90 days after surgery. (D) Stereological quantification of the number of eGFP+ cells in the OB at 7 days (84± 24, n = 2), 14 days (225± 48,
n =4) and 90days (825±167, n=7) after stroke. 3 months after stroke, thenumber of eGFP+ cellswas significantly higher compared to 7 days after stroke (Kruskal-Wallis test p b 0.05,
followed by Dunn's post test p b 0.05). The time-dependent increase corresponds to the migration of eGFP+ eNSC progeny from the SVZ to the OB.
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imal with the largest MCAO stroke lesion, there was no re-location of
the BLI signal, most likely due to the large stroke size and its location,
which restrains themigration and localization of the labeled cellswithin
a region of the ischemic striatum (Ohab and Carmichael, 2008).
In the group receiving PT stroke, long-term BLI follow-up revealed a
clear BLI signal between the eyes in 5 out of 8 animals at 3 months after
stroke, in line with migration of eNSC progeny to the OB (Fig. 4B). The
origin of BLI signal emerging from the OBwas corroborated histologically
by a gradual increase in the number of eGFP+ cells in the OB over time,
being 2.7 ± 0.6 fold higher at 14 days (not significant) and 12.8 ± 2.0
fold higher (p b 0.05) at 90 days compared to 7 days after stroke surgery
(Figs. 5C,D). These results provide additional evidence that the LV-Cre-
Flex specifically labeled the eNSCs in the SVZ.
In conclusion, injection of LV-Cre-Flex in the SVZ of Nestin-Cre mice
allowed monitoring both the migration of eNSC progeny from the SVZ
to the stroke region and to the OB with BLI.
eNSC progeny differentiates into astrocytes and neurons in the peri-infarct
region
Since injection of LV-Cre-Flex in Nestin-Cre mice results in the
expression of Fluc and eGFP in the eNSCs and their progeny, a detailed
histological analysis of the transduced cell population and its progeny
can be performed. In animals killed 90 days after PT stroke, light produc-
ing cells (152 ± 30 eGFP+ cells counted per animal, n = 3) were
identified by double and triple immunofluorescence stainings (eGFP in
combination with GFAP or DCX and NeuN (Fig. 6)). In the SVZ and the
CC, 77 ± 7% of eGFP+ cells were GFAP+ eNSCs and astrocytes, 8 ± 2%
were DCX+ migrating neuroblasts and b1% were NeuN+ matureneurons (Figs. 6A,C,E). A different pattern of cellular phenotypes was
detected in the peri-infarct region: 36 ± 5% of eGFP+ cells were
GFAP+ astrocytes, 13 ± 11% were DCX+ migrating neuroblasts, 5 ±
3% were DCX+NeuN+ immature neurons and 21 ± 16% were NeuN+
mature neurons (Figs. 6B,D,E). Evaluation of differentiation into mature
neurons, displayed a high inter-animal variability, with one animal
showing 50% of eGFP+ cells co-expressing NeuN in the peri-infarct
region, while the other two animals showed less than 10% co-
expression. In the first animal, some eGFP+ neurons showed long den-
drites covered with many spines (Fig. 6F). These data indicate that the
labeled eNSCs in the SVZ gave rise to progeny that migrated towards
the stroke region where they eventually differentiated into both astro-
cytes and mature neurons.
Discussion
Detailed knowledge of the biological role and potential of eNSCs is of
great importance for the success of neuro-regenerative therapies in dif-
ferent neurological disorders, including stroke. Therefore, development
of non-invasive methods to monitor and study proliferation, migration
and survival of eNSCs and their progeny in the same animal over time
is crucial. Themain advantage of cell tracking via BLI is the high sensitiv-
ity, especially when cells are located in superficial tissues (Massoud and
Gambhir, 2003). The present study demonstrates non-invasive imaging
of the eNSC response after PT stroke in a mouse model using BLI. First,
we generated double transgenic Nestin-CreERT2/Fluc mice, in which
Fluc expression is induced in the eNSCs after tamoxifen administration.
After stroke, these mice showed an increase in BLI signal in vivo (n =
6/8) and ex vivo (n = 3/8) originating from the stroke lesion (Figs. 2B,
C). The discrepancy in efficiency between the in vivo and ex vivo results
Fig. 6. Labeled eNSCs differentiate into astrocytes and neurons in the stroke region. (A,B) Double immunofluorescence staining for eGFP (green) and GFAP (red) of the CC (A) and stroke
region (B) of the ipsilateral hemisphere 90 days after stroke. Filled white arrowheads indicate eGFP+ eNSCs and astrocytes. (C,D) Triple immunofluorescence staining for eGFP (green),
DCX (red) and NeuN (blue) of the CC (C) and stroke region (D). (C) Filled white arrowheads indicate eGFP+ migrating neuroblasts. (D) Filled white arrowheads and arrow indicate
eGFP+ mature neurons. (E) Quantification of double and triple labeled cells. (F) Magnification of eGFP+ neuron indicated with arrow in (D). Scale bar: (A–D) = 100 μm; (F) = 25 μm.
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the brain tissue immediately after sacrifice, which causes differences in
oxygenation status of the tissue and enzymatic activity (Deroose et al.,
2006). In the latter model it was impossible to define the origin of the
cells giving rise to the BLI signal emerging from the stroke area, which
might either originate from accumulation of migrating SVZ progeny or
from dedifferentiation of local mature astrocytes upon injury, resulting
in nestin and subsequently, Fluc expression (Buffo et al., 2008). More-
over, although Fluc is expressed in eNSCs of the SVZ and eventually in
the progeny arriving in the OB, as was evidenced by ex vivo BLI (Figs.
1D, E), the number of labeled cells or the expression level of Fluc per
cell was too low for in vivo detection (Figs. 1A–C). In this way, the effect
of stroke on the neurogenic process towards the OB could also not be
monitored.
In a secondapproach,we circumvented these drawbacks by devising
conditional Cre-Flex LVs to inject in the SVZ of Nestin-Cre mice. Specific
induction of Fluc and eGFP in the eNSCs and their progeny allows both
BLI and immunohistochemical characterization of the neurogenic pro-
cess. In contrast to the first approach using double transgenic mice,
in vivo BLI signals from the SVZ and eventually from the OB could be de-
tected (Fig. 3C), most probably due to the higher Fluc expression levels.
Induction of a PT stroke resulted in a significant gradual increase in BLI
signal between 2 days and 2 weeks after surgery (Figs. 4B,D). The latter
was underscored by an increase in eGFP+ cells in the SVZ, striatum, CC
and stroke region (Fig. 5B). Subsequently, the BLI signal and the number
of eGFP+ cells decreased to background levels at 3 months after stroke.
This transient increase in eNSC progeny is in accordancewith two stud-
ies describing a transient increase in the proliferation and migration of
eNSCs following stroke or brain trauma, detected by histology using
cell type-specific markers (Parent et al., 2002) or by retroviral labeling
of SVZ cells (Goings et al., 2004). Parent et al. showed that the number
of BrdU-labeled cells was lower 5 weeks after stroke compared to pre-
vious time points, suggesting that many of the newly generated cells
died (Parent et al., 2002).
In Nestin-Cre mice injected with the Cre-Flex LV, a clear
relocalization of the BLI signal towards the stroke area was detected
between 1 and 2 weeks after stroke surgery. This was confirmed histo-
logically by eGFP+ cells moving closer towards the ischemic lesion over
time (Figs. 4B and 5A). The 1–2 weeks time frame of this migration is in
agreement with the work of Ohab et al. who detected GFP+ cells, origi-
nating from the SVZ, in the peri-infarct cortex 7 and 14 days after stroke
(Ohab et al., 2006). When monitoring eNSC migration after stroke with
BLI, we encountered some technical hurdles. First, edema formation
causes a shift of the midline, resulting in a slight apparent re-location
of the BLI spot towards the contralateral hemisphere, complicating
detection of eNSC migration towards the lesion at early time points.
Second, changes in ventricle size, due to tissue degeneration after stroke
may confound the imaging results (Karki et al., 2010). Therefore, we
combined BLI with MRI, which has a high spatial resolution and gives
better insight in alterations of the anatomical structure of the brain.
Since labeled cells express a fluorescent reporter (eGFP) in addition
to the bioluminescent Fluc reporter, the origin and identity of light emit-
ting cells could be determined by immunohistochemical stainings.
Ninety days after stroke, labeled eNSC progeny differentiated into
both astrocytes and mature neurons, demonstrating the multipotency
of eNSCs upon stroke injury (Arvidsson et al., 2002; Goings et al.,
2004; Parent et al., 2002). The majority of eGFP+ labeled cells in the
SVZ, CC and the stroke region expressed GFAP, corroborating astrocytic
differentiation of eNSC progeny after cortical injury (Goings et al., 2004;
Holmin et al., 1997). In addition, using tamoxifen-inducible Nestin-
CreERT2:R26R-YFP reporter mice, Li et al. demonstrated that 45% of
eNSC progeny co-expressed GFAP 6 weeks after MCAO, indicating a
significant gliogenic component (Li et al., 2010).
Since stroke injury might induce nestin expression in reactive astro-
cytes (Buffo et al., 2008; Shimada et al., 2010; Sirko et al., 2013) or in
vasculature-associated cells in the ischemic core (Shin et al., 2013),one could question the source of the eGFP+ cells located around the
ischemic lesion. However, it has been well described that reactive
astrocytes are mainly present in the close vicinity of the stroke region.
Unbiased stereological quantifications of astrocyte proliferation, a hall-
mark of reactive gliosis, showed that astrocytes respond to stroke injury
in a spatially gradedway (Barreto et al., 2011). The authors showed that
most astrocyte proliferation occurs within 200 μm of the edge of the
infarct. In addition, nestin upregulation of reactive astrocytes has been
shown to be confined to the peri-infarct region, or to clearly demarcate
the lesion boundary (Li and Chopp, 1999; Shimada et al., 2010). Since
we injected the Cre-Flex LV in the SVZ, which is physically distant
from the stroke region, and since we did not detect any changes in Cre
expression in the SVZ or CC, we consider it unlikely to label local reac-
tive astrocytes around the stroke region. Another indication that argues
against local reactive astrocytes as the main origin of labeled cells con-
cerns the localization of the BLI signal: if the 4.3 fold increase in BLI sig-
nal two days after stroke would be caused by labeling of reactive
astrocytes, one would expect appearance of a new BLI spot emerging
from the stroke region, or a shift of the existing SVZ BLI spot towards
the stroke region. However, we show that this is not the case and that
there is even a small shift of the original SVZ BLI spot towards the con-
tralateral side (Fig. 4B). A clear migration of the BLI spot towards the
stroke region was only apparent after 7–14 days after stroke. Our data
strongly suggest migration of the progeny of transduced eNSCs via the
CC to the stroke lesion. The increase in BLI signal between the eyes
and the corresponding increase in the number of eGFP+ cells in the
OB over time, points to the migration of labeled eNSC progeny from
the SVZ to the OB, proving that the eNSCs in the SVZ were labeled by
the Cre-Flex LV. Several research groups have shown a reduction or
diversion of normal neuroblast migration from the SVZ to the OB at
early time points after cortical lesion or stroke (Goings et al., 2004;
Ohab et al., 2006). The Cre-Flex LV technology will allow longitudinal
non-invasive imaging of the effects of brain lesions on rostralmigration.
The present study focuses on the response of SVZ-derived Nestin+
eNSCs on stroke injury. However, none of the eNSC markers currently
available exclusively labels eNSCs and evidence emerges suggesting
eNSC heterogeneity both in the SVZ (Giachino et al., 2013) and the
SGZ (Bonaguidi et al., 2012; DeCarolis et al., 2013). It would therefore
be interesting to apply the Cre-Flex LVs in different transgenic mice to
compare the contribution of different progenitor populations to the
stroke-induced neurogenic response (Dhaliwal and Lagace, 2011). In
addition, the Cre-Flex LVs might also be used to study eNSC response
in other disease models (Guglielmetti et al., 2013).
In conclusion, we developed a novel technique based on conditional
Cre-Flex LVs that allows non-invasive imaging of the stroke-induced
eNSC response in living mice with BLI. In addition, this new technique
enables fatemapping of the eNSC progeny after stroke by immunohisto-
chemistry. Our BLI and histological data are consistent with the prevail-
ing hypothesis that stroke induces a transient increase in proliferation
in the SVZ, a targetedmigration of eNSC progeny towards the stroke re-
gion and differentiation in both astrocytes and neurons. For this reason,
we believe that this technology may facilitate preclinical validation of
neuro-regenerative strategies in rodent stroke models.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2014.05.014.
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